These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21692185)

  • 21. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents.
    Wieland HA; Engel W; Eberlein W; Rudolf K; Doods HN
    Br J Pharmacol; 1998 Oct; 125(3):549-55. PubMed ID: 9806339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [³H]UR-MK136: a highly potent and selective radioligand for neuropeptide Y Y₁ receptors.
    Keller M; Bernhardt G; Buschauer A
    ChemMedChem; 2011 Sep; 6(9):1566-71. PubMed ID: 21732539
    [No Abstract]   [Full Text] [Related]  

  • 23. Functional reconstitution of human neuropeptide Y (NPY) Y(2) and Y(4) receptors in Sf9 insect cells.
    Pop N; Igel P; Brennauer A; Cabrele C; Bernhardt GN; Seifert R; Buschauer A
    J Recept Signal Transduct Res; 2011 Aug; 31(4):271-85. PubMed ID: 21745157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
    Kanatani A; Kanno T; Ishihara A; Hata M; Sakuraba A; Tanaka T; Tsuchiya Y; Mase T; Fukuroda T; Fukami T; Ihara M
    Biochem Biophys Res Commun; 1999 Dec; 266(1):88-91. PubMed ID: 10581170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformations, conformational preferences, and conformational exchange of N'-substituted N-acylguanidines: intermolecular interactions hold the key.
    Kleinmaier R; Keller M; Igel P; Buschauer A; Gschwind RM
    J Am Chem Soc; 2010 Aug; 132(32):11223-33. PubMed ID: 20698689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and structure activity relationship of guanidines as NPY Y5 antagonists.
    Aquino CJ; Ramanjulu JM; Heyer D; Daniels AJ; Palazzo F; Dezube M
    Bioorg Med Chem; 2004 May; 12(10):2691-708. PubMed ID: 15110851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY.
    Balasubramaniam A; Ujhelyi M; Borchers M; Huang Y; Zhai W; Zhou Y; Johnson M; Sheriff S; Fischer JE
    J Med Chem; 1996 Mar; 39(5):1142-7. PubMed ID: 8676351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo.
    Mullins D; Kirby D; Hwa J; Guzzi M; Rivier J; Parker E
    Mol Pharmacol; 2001 Sep; 60(3):534-40. PubMed ID: 11502885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
    Cabrele C; Beck-Sickinger AG
    J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships of neuropeptide Y Y1 receptor antagonists related to BIBP 3226.
    Aiglstorfer I; Hendrich I; Moser C; Bernhardt G; Dove S; Buschauer A
    Bioorg Med Chem Lett; 2000 Jul; 10(14):1597-600. PubMed ID: 10915060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
    Tu B; Jiao Y; Herzog H; Nadler JV
    Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of G proteins by neuropeptide Y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action.
    Odagaki Y; Nishi N; Nakagawa S; Koyama T
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1250-6. PubMed ID: 10565849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
    Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Food intake regulation in rodents: Y5 or Y1 NPY receptors or both?
    Duhault J; Boulanger M; Chamorro S; Boutin JA; Della Zuana O; Douillet E; Fauchère JL; Félétou M; Germain M; Husson B; Vega AM; Renard P; Tisserand F
    Can J Physiol Pharmacol; 2000 Feb; 78(2):173-85. PubMed ID: 10737680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
    Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
    J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
    Sautel M; Rudolf K; Wittneben H; Herzog H; Martinez R; Munoz M; Eberlein W; Engel W; Walker P; Beck-Sickinger AG
    Mol Pharmacol; 1996 Aug; 50(2):285-92. PubMed ID: 8700135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPC receptors and not ligands decide the binding mode in neuropeptide Y multireceptor/multiligand system.
    Lindner D; van Dieck J; Merten N; Mörl K; Günther R; Hofmann HJ; Beck-Sickinger AG
    Biochemistry; 2008 Jun; 47(22):5905-14. PubMed ID: 18457425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
    Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
    J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide Y Y1 receptor antagonists.
    Dove S; Michel MC; Knieps S; Buschauer A
    Can J Physiol Pharmacol; 2000 Feb; 78(2):108-15. PubMed ID: 10737673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.